ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

McGill University Health Centre/Research Institute of the McGill University Health Centre · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
closeddiabetesmellitusglpinsulinsemaglutidetype1diabetes
type 1 diabetes, diabetes mellitus, type 1, insulin, closed-loop system, glp-1 receptor agonist, semaglutide, artificial pancreas, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 896241
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.